Effect of OTX-101 0.09% ciclosporin solution on clinical signs of dry eye disease in patients with moderate-to-severe corneal damage: a post-hoc analysis of randomized clinical trials.

چکیده

This post-hoc analysis of two OTX-101 clinical trials assessed the efficacy of 0.09% ciclosporin in treating dry eye disease (DED) patients with moderate-to-severe corneal damage. The criteria for moderate-to-severe corneal damage were defined as a CFS total score (5 zones) of ≥ 6 or single…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• خشکی چشم
• قرنیه